News
07th of May 2024: Do your methods comply with the new ICH requirements?
22th of August 2023: Prohibition of PFAS – Evaluate, assess risks, time to act
13th of April 2023: SMEPAC Test to Measure the Tightness of Containment Systems
29th of August 2022: Computerized System Validation (CSV) – GAMP 5 Second Edition
1th of June: New ICH Q14 Guideline: Analytical procedure development
18th of February: Revision of ICH Q9 (R1) Guideline on Quality Risk Management
15th of April 2021: WHO publishes decision on setting acceptance criteria for cleaning validation
8th of January 2021: Integrated Qualification and Validation Guide
2th of December 2020: Good Manufacturing Practice (GMP)
26th of October 2020: Nitrosamines in active substances and finished medicinal products
15th of June 2020: Current trends and outlook on cleanroom requirements
12th of June 2020: Pharmaceutical procurement & supplier qualification
10th of June 2024: Robotics and Automation for ATMPs
5th of December 2023: The first CRISPR/Cas9-based therapy has reached the market
10th of November 2023: Transferring novel therapies succesfully to patients and market
4th of February 2021: Vaccinations with mRNA-based medicinal products
9th of October 2020: 2nd APV Interactive Workshop on ATMP
24th of September 2020: MSC & Covid-19
24th of August 2020: FDA opens up approval process for RYONCYL™
4th of August 2020: FDA approves CAR T-cell therapy Tecartus™
17th of January 2020: BioNTech SE acquires Neon Therapeutics
9th of January 2020: New legal regulations governing the application of ATMPs
Our international press review contains a selection of news and recent articles on advanced therapy medicinal products (ATMPs), chimeric antigen receptor T-cell therapy (CAR), tumor infiltrating lymphocytes (TILs) and bioengineered tissue products (TEPs).
Review top news and interview highlights from the week ending June 28, 2024.
Teilen: 28.06.2024 12:20 Forschungserfolg durch erste umfassende Untersuchung des Genoms und Proteoms ...
Cancer therapy is ever changing as technology improves to better understand our immune systems. Immunotherapy is a form of cancer treatment ...
Die Amyotrophe Lateralsklerose (ALS) ist eine unheilbare, schwere Erkrankung des Nervensystems. In ihrem Verlauf sammeln ...
People have been trying for decades to get “vaccines” and “cancer” into the same sentence, and it’s no wonder. Vaccines can be tremendous ...
Findings from the EPCORE NHL-1 trial support the FDA approval of epcoritamab in relapsed/refractory follicular lymphoma.
Wound care solutions are essential in medicine to protect injuries from infection, manage exudate, and create an optimal healing ...
HIRI-Forschende entwickeln neuen Ansatz zur DNA-Transformation und Genmutation in Bakterien
Author links open overlay panelMatthew A. Nix 1 2, Arun P. Wiita 1 3 4 5
CT-0525 has received a fast track designation from the FDA for the treatment of solid tumors that overexpress HER2.
A container closure system (CCS) is comprised of packaging components, such as a vial and stopper, that together, contain and protect the ...
Das Projekt wird maßgeblich von der Bundesregierung sowie dem Land Berlin finanziell gefördert und unterstützt. ...
SPONSOR
Review top news and interview highlights from the week ending June 21, 2024.
An der Uniklinik Düsseldorf wurde der erste Sklerodermie-Patient unter Einsatz der CAR-T-Zell- ...
Dr. Ellen Sons-Brinkmann
Tel: +49 69 153 293 709
Mail.: ellen.sons-brinkmann@valicare.com